CW ClaimWatch Consumer alert tracker

Recall

Acella Pharmaceuticals, LLC: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Recall

Chemical contamination; presence of lead and lithium above specification Product details: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Active Official source

Verification

Official-source record

This page is included in the public index because it is tied to a listed official source. ClaimWatch does not publish trend-only candidates to public SEO pages.

Agency
FDA
Record ID
D-0523-2026
Canonical
https://claimwatch-mvp.vercel.app/item/acella-pharmaceuticals-llc-naproxen-oral-suspension-usp-125-mg-5ml-rx-only-16fl-oz-473-ml-/

What happened?

Chemical contamination; presence of lead and lithium above specification Product details: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Who may be affected?

Nationwide

What should consumers do?

Affected quantity: 6,336 bottles

Official source

Matched search terms

No search trend terms attached yet.

FAQ

Is this page official?

No. ClaimWatch links to official sources and marks whether a page is verified or still being monitored.

Is this legal, medical, or financial advice?

No. This page is informational. Always confirm eligibility, deadlines, and safety instructions through official sources.

Similar alerts